METASTATIC ADENOCARCINOMA OF THE PANCREAS
Clinical trials for METASTATIC ADENOCARCINOMA OF THE PANCREAS explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ADENOCARCINOMA OF THE PANCREAS trials appear
Sign up with your email to follow new studies for METASTATIC ADENOCARCINOMA OF THE PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for pancreatic cancer: drug combo shows promise in early trial
Disease control CompletedThis study tested a combination of four drugs (irinotecan liposome, oxaliplatin, 5-FU, and leucovorin) in 41 Japanese adults with advanced pancreatic cancer that had not been treated before. The goal was to see if the treatment could shrink tumors and to check its safety. Partici…
Matched conditions: METASTATIC ADENOCARCINOMA OF THE PANCREAS
Phase: PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated May 17, 2026 08:17 UTC
-
New chemo cocktail shows promise in battle against pancreatic cancer
Disease control CompletedThis study tested two different chemotherapy combinations in 770 people with advanced pancreatic cancer that had not been treated before. One group received a new liposomal form of irinotecan plus other standard drugs, while the other group received a standard combination of nab-…
Matched conditions: METASTATIC ADENOCARCINOMA OF THE PANCREAS
Phase: PHASE3 • Sponsor: Ipsen • Aim: Disease control
Last updated May 14, 2026 12:02 UTC